Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Raphael P. Davis"'
Autor:
Linda M. Liau, Keyoumars Ashkan, David D. Tran, Jian L. Campian, John E. Trusheim, Charles S. Cobbs, Jason A. Heth, Michael Salacz, Sarah Taylor, Stacy D. D’Andre, Fabio M. Iwamoto, Edward J. Dropcho, Yaron A. Moshel, Kevin A. Walter, Clement P. Pillainayagam, Robert Aiken, Rekha Chaudhary, Samuel A. Goldlust, Daniela A. Bota, Paul Duic, Jai Grewal, Heinrich Elinzano, Steven A. Toms, Kevin O. Lillehei, Tom Mikkelsen, Tobias Walbert, Steven R. Abram, Andrew J. Brenner, Steven Brem, Matthew G. Ewend, Simon Khagi, Jana Portnow, Lyndon J. Kim, William G. Loudon, Reid C. Thompson, David E. Avigan, Karen L. Fink, Francois J. Geoffroy, Scott Lindhorst, Jose Lutzky, Andrew E. Sloan, Gabriele Schackert, Dietmar Krex, Hans-Jorg Meisel, Julian Wu, Raphael P. Davis, Christopher Duma, Arnold B. Etame, David Mathieu, Santosh Kesari, David Piccioni, Manfred Westphal, David S. Baskin, Pamela Z. New, Michel Lacroix, Sven-Axel May, Timothy J. Pluard, Victor Tse, Richard M. Green, John L. Villano, Michael Pearlman, Kevin Petrecca, Michael Schulder, Lynne P. Taylor, Anthony E. Maida, Robert M. Prins, Timothy F. Cloughesy, Paul Mulholland, Marnix L. Bosch
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-9 (2018)
Abstract Background Standard therapy for glioblastoma includes surgery, radiotherapy, and temozolomide. This Phase 3 trial evaluates the addition of an autologous tumor lysate-pulsed dendritic cell vaccine (DCVax®-L) to standard therapy for newly di
Externí odkaz:
https://doaj.org/article/7b4a8b2c7d344b0e9344d197a7338b0a
Autor:
Linda M. Liau, Keyoumars Ashkan, David D. Tran, Jian L. Campian, John E. Trusheim, Charles S. Cobbs, Jason A. Heth, Michael Salacz, Sarah Taylor, Stacy D. D’Andre, Fabio M. Iwamoto, Edward J. Dropcho, Yaron A. Moshel, Kevin A. Walter, Clement P. Pillainayagam, Robert Aiken, Rekha Chaudhary, Samuel A. Goldlust, Daniela A. Bota, Paul Duic, Jai Grewal, Heinrich Elinzano, Steven A. Toms, Kevin O. Lillehei, Tom Mikkelsen, Tobias Walbert, Steven R. Abram, Andrew J. Brenner, Steven Brem, Matthew G. Ewend, Simon Khagi, Jana Portnow, Lyndon J. Kim, William G. Loudon, Reid C. Thompson, David E. Avigan, Karen L. Fink, Francois J. Geoffroy, Scott Lindhorst, Jose Lutzky, Andrew E. Sloan, Gabriele Schackert, Dietmar Krex, Hans-Jorg Meisel, Julian Wu, Raphael P. Davis, Christopher Duma, Arnold B. Etame, David Mathieu, Santosh Kesari, David Piccioni, Manfred Westphal, David S. Baskin, Pamela Z. New, Michel Lacroix, Sven-Axel May, Timothy J. Pluard, Victor Tse, Richard M. Green, John L. Villano, Michael Pearlman, Kevin Petrecca, Michael Schulder, Lynne P. Taylor, Anthony E. Maida, Robert M. Prins, Timothy F. Cloughesy, Paul Mulholland, Marnix L. Bosch
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-2 (2018)
Following publication of the original article [1], the authors reported an error in the spelling of one of the author names. In this Correction the incorrect and correct author names are indicated and the author name has been updated in the original
Externí odkaz:
https://doaj.org/article/523386e861dd4740aa938b4e7fa9768c
Autor:
Charles B. Mikell, Sofia Geralemou, Wesam Andraous, Erica Shen, Christopher R. Page, Colleen Calandra, Raphael P. Davis
Publikováno v:
Journal of Clinical Neuroscience. 67:221-225
Most current awake craniotomy techniques utilize unnecessarily complicated airway management, and cause discomfort to the patients during the awake phase of the surgery. Our manuscript is written to discuss the neurosurgical and anesthetic techniques
Autor:
Raphael P. Davis, Elliott Bennett-Guerrero, Justin Smith, Stephen Probst, Colleen Calandra, Kentaro Sugimoto, Tong J. Gan, Lizhou Nie
Publikováno v:
Perioperative Medicine
Perioperative Medicine, Vol 8, Iss 1, Pp 1-9 (2019)
Perioperative Medicine, Vol 8, Iss 1, Pp 1-9 (2019)
Background There is a paucity of literature regarding the implementation of enhanced recovery after surgery (ERAS) protocols for open lumbar spine fusions. We implemented an ERAS program for 1–2-level lumbar spine fusion surgery and identified area
Autor:
Samuel Goldlust, Tom Mikkelsen, Reid C. Thompson, David Avigan, John E. Trusheim, Marnix L. Bosch, Kevin Petrecca, David S. Baskin, David Mathieu, Sarah A. Taylor, Timothy F. Cloughesy, Jian Campian, Raphael P. Davis, Christopher Duma, Lyndon Kim, Robert M. Prins, Kevin A. Walter, Keyoumars Ashkan, Scott Lindhorst, Tobias Walbert, Andrew E. Sloan, John L. Villano, Daniela A. Bota, Simon Khagi, Santosh Kesari, David Piccioni, Michael Salacz, Manfred Westphal, Steven A. Toms, Jose Lutzky, Dietmar Krex, Linda M. Liau, Timothy J. Pluard, Paul Duic, Richard M. Green, Rekha Chaudhary, Clement Pillainayagam, Andrew Brenner, Fabio M. Iwamoto, Steven Brem, Heinrich Elinzano, Edward J. Dropcho, Karen Fink, Hans Jorg Meisel, Michael Pearlman, Michel Lacroix, Jason Heth, Julian Wu, Lynne Taylor, Kevin O. Lillehei, Stacy D. D’Andre, Pamela Z. New, Gabriele Schackert, Arnold B. Etame, David Tran, Steven R. Abram, Jai Grewal, Paul Mulholland, William G. Loudon, Sven Axel May, Francois J. Geoffroy, Victor Tse, Robert Aiken, Matthew G. Ewend, Anthony E. Maida, Michael Schulder, Jana Portnow, Charles S. Cobbs, Yaron A. Moshel
Publikováno v:
Liau, Linda M; Ashkan, Keyoumars; Tran, David D; Campian, Jian L; Trusheim, John E; Cobbs, Charles S; et al.(2018). Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.. Journal of translational medicine, 16(1), 179. doi: 10.1186/s12967-018-1552-1. UC Office of the President: Research Grants Program Office (RGPO). Retrieved from: http://www.escholarship.org/uc/item/1k3480p0
Journal of Translational Medicine
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-2 (2018)
Journal of Translational Medicine
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-2 (2018)
Background Standard therapy for glioblastoma includes surgery, radiotherapy, and temozolomide. This Phase 3 trial evaluates the addition of an autologous tumor lysate-pulsed dendritic cell vaccine (DCVax®-L) to standard therapy for newly diagnosed g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c249b32746a18134ef143a85ab82d24
http://www.escholarship.org/uc/item/1k3480p0
http://www.escholarship.org/uc/item/1k3480p0
Autor:
Manfred Westphal, Dietmar Krex, Rekha Chaudhary, Christopher Duma, Jana Portnow, Tom Mikkelsen, Reid C. Thompson, Edward J. Dropcho, Charles S. Cobbs, Sven-Axel May, Santosh Kesari, Michel Lacroix, Raphael P. Davis, David Avigan, Robert M. Prins, Jian Campian, Keyoumars Ashkan, John L. Villano, Yaron A. Moshel, John E. Trusheim, David Piccioni, Timothy J. Pluard, Paul Duic, Timothy F. Cloughesy, Michael Salacz, Andrew Brenner, Daniela A. Bota, Stacy D. D’Andre, Jai Grewal, Victor Tse, Steven A. Toms, Jason Heth, Lyndon Kim, Clement Pillainayagam, David S. Baskin, David Tran, Kevin A. Walter, Steven R. Abram, Andrew E. Sloan, Richard M. Green, Julian Wu, Scott Lindhorst, Simon Khagi, Heinrich Elinzano, Matthew G. Ewend, Paul Mulholland, Fabio M. Iwamoto, Anthony E. Maida, Michael Schulder, Kevin O. Lillehei, Karen Fink, Robert Aiken, Lynne Taylor, Hans-Jorg Meisel, William G. Loudon, Arnold B. Etame, Francois J. Geoffroy, Sarah A. Taylor, Pamela Z. New, Steven Brem, Gabriele Schackert, David Mathieu, Marnix L. Bosch, Tobias Walbert, Linda M. Liau, Michael Pearlman, Kevin Petrecca, Samuel Goldlust, Jose Lutzky
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-9 (2018)
Liau, Linda M; Ashkan, Keyoumars; Tran, David D; Campian, Jian L; Trusheim, John E; Cobbs, Charles S; et al.(2018). First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.. Journal of translational medicine, 16(1), 142. doi: 10.1186/s12967-018-1507-6. UC Office of the President: Research Grants Program Office (RGPO). Retrieved from: http://www.escholarship.org/uc/item/4zs134n7
Journal of Translational Medicine
Liau, Linda M; Ashkan, Keyoumars; Tran, David D; Campian, Jian L; Trusheim, John E; Cobbs, Charles S; et al.(2018). First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.. Journal of translational medicine, 16(1), 142. doi: 10.1186/s12967-018-1507-6. UC Office of the President: Research Grants Program Office (RGPO). Retrieved from: http://www.escholarship.org/uc/item/4zs134n7
Journal of Translational Medicine
Background Standard therapy for glioblastoma includes surgery, radiotherapy, and temozolomide. This Phase 3 trial evaluates the addition of an autologous tumor lysate-pulsed dendritic cell vaccine (DCVax®-L) to standard therapy for newly diagnosed g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7eee1a79d20bdb89286ba57579f8eecf
Publikováno v:
American journal of orthopedics (Belle Mead, N.J.). 46(2)
We conducted a study to evaluate the operative details, perioperative complications, and short-term outcomes associated with combined anterior-posterior decompression and fusion (CAPDF) for treating cervical spondylotic myelopathy (CSM). We retrospec
Publikováno v:
Journal of Neuroscience and Neuroengineering. 3:62-71
Publikováno v:
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 41
Background A major challenge during endoscopic transsphenoidal surgery is adequate intraoperative hemostasis. The Aquamantys® is a relatively new bipolar sealing device which uses radiofrequency energy and saline. This promotes hemostasis while decr
Autor:
George J. Kaptain, David Schiff, Nam D. Tran, Alexander Lossos, Ryan Merrell, David W. Macdonald, James Perry, Garth Nicholas, Raphael P. Davis, Karen Fink, J. Bradley Elder, Manmeet Ahluwalia, Tobias Walbert, Michael Salacz, Reid C. Thompson, Fairooz F. Kabbinavar, Jason Heth, Denise Damek, Thian Kheoh, Nina L. Martinez, Timothy F. Cloughesy, Daniela A. Bota, Marshall Pitz, Seema Nagpal, Yaron A. Moshel, Jay-Jiguang Zhu, Do-Hyun Nam, David Picconi, Fabio M. Iwamoto, Clark C. Chen, Nicholas Butowski, Gelareh Zadeh, Joseph Landolfi, Chul-Kee Park, Rohan Ramakrishna, Kevin Petrecca, H. Ian Robins, David Tran, Michael A. Vogelbaum, Steven Brem, Dimitris G. Placantonakis, David Cachia, Chetan Bettegowda, Vivek Mehta, Michael Pearlman, Deborah Heros, Nimish Mohile
Publikováno v:
Neuro Oncol
BACKGROUND Toca 511 (vocimagene amiretrorepvec) is a cancer-selective, retroviral replicating vector encoding a codon optimized, heat stabilized cytosine deaminase that converts Toca FC (extended-release 5-fluorocytosine, 5-FC) into the anticancer ag